- Home
- SQM vs QGEN Comparison
SQM vs QGEN Comparison
Compare SQM & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SQM | QGEN |
|---|---|---|
| Founded | 1968 | 1986 |
| Country | Chile | Netherlands |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.6B | 10.2B |
| IPO Year | 1993 | 1996 |
Fundamental Metrics
Financial Performance| Metric | SQM | QGEN |
|---|---|---|
| Price | $61.39 | $47.05 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $50.81 | $50.68 |
| AVG Volume (30 Days) | ★ 2.1M | 1.2M |
| Earning Date | 11-18-2025 | 11-04-2025 |
| Dividend Yield | ★ 3.45% | 3.21% |
| EPS Growth | N/A | ★ 331.20 |
| EPS | 1.84 | ★ 1.84 |
| Revenue | ★ $4,326,111,000.00 | $2,070,781,000.00 |
| Revenue This Year | N/A | $7.12 |
| Revenue Next Year | $22.11 | $6.13 |
| P/E Ratio | $33.36 | ★ $25.56 |
| Revenue Growth | N/A | ★ 5.32 |
| 52 Week Low | $29.36 | $37.63 |
| 52 Week High | $65.65 | $51.88 |
Technical Indicators
Market Signals| Indicator | SQM | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 61.38 | 55.46 |
| Support Level | $59.97 | $46.39 |
| Resistance Level | $65.65 | $48.13 |
| Average True Range (ATR) | 2.39 | 0.67 |
| MACD | -0.26 | 0.18 |
| Stochastic Oscillator | 48.65 | 68.53 |
Price Performance
Historical ComparisonAbout SQM Sociedad Quimica y Minera S.A.
Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM also sells lithium concentrate from a joint venture hard rock lithium project in Australia and expanding its lithium refining assets in China.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).